Loratadine and Eucrisa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loratadine (loratadine) and Eucrisa (crisaborole). Common drug interactions include sleep disorder among females and dermatitis atopic among males.

The phase IV clinical study analyzes what interactions people have when they take Loratadine and Eucrisa. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Loratadine?

Loratadine has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 56,315 Loratadine users. Check the latest studies of Loratadine.

What is Eucrisa?

Eucrisa has active ingredients of crisaborole. eHealthMe is studying from 9,900 Eucrisa users. Check the latest studies of Eucrisa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

66 people who take Loratadine and Eucrisa together, and have interactions are studied.

Loratadine and Eucrisa drug interactions.

What are the common drug interactions of Loratadine and Eucrisa, by gender? *:

female:

Sleep disorder
Status asthmaticus (a asthma attack not responds to regular medicines)
Swelling
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Therapeutic response decreased (less preventive response)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Rash
Arthralgia (joint pain)
Cough
Drug ineffective

male:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Injection site mass
Drug ineffective
Dysphonia (speech disorder attributable to a disorder of phonation)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Foreign body sensation in eyes (feeling of something in eye)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypersensitivity
Injection site pain
Injection site swelling

What are the common drug interactions of Loratadine and Eucrisa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Burning sensation
Contusion (a type of hematoma of tissue in which capillaries)
Dry skin
Head injury
Injection site pain
Injection site rash
Insomnia (sleeplessness)
Nasopharyngitis (inflammation of the nasopharynx)
Pain
Pruritus (severe itching of the skin)

10-19:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Arthralgia (joint pain)
Alopecia (absence of hair from areas of the body)
Back pain
Dry skin
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Headache (pain in head)
Hypersensitivity
Influenza
Nerve compression

20-29:

Injection site mass
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Dry eye (lack of adequate tears)
Cough
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Influenza
Malaise (a feeling of general discomfort or uneasiness)

30-39:

Pneumonia

40-49:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Rash
Conjunctivitis (pink eye)
Abdominal distension
Coeliac artery compression syndrome (abdominal pain related to compression of the celiac artery)
Foreign body sensation in eyes (feeling of something in eye)
Hepatic steatosis (fatty liver disease)
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Liver injury

50-59:

Drug ineffective
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Erythema (redness of the skin)
Infection
Injection site reaction
Injection site swelling
Peripheral swelling
Rash
Rash macular (small, flat red spots)

60+:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Lymphadenopathy (disease or enlargement of lymph nodes)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Muscle spasms (muscle contraction)
Nausea (feeling of having an urge to vomit)
Respiratory disorder (respiratory disease)
Sinusitis (inflammation of sinus)
Upper respiratory tract infection
Vomiting

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 48 people, 72.73%
Asthma: 6 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Loratadine and Eucrisa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously